Volgen
S Senan
S Senan
radiotherapie, Amsterdam University Medical Centers
Geverifieerd e-mailadres voor amsterdamumc.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
PE Postmus, KM Kerr, M Oudkerk, S Senan, DA Waller, J Vansteenkiste, ...
Annals of oncology 28, iv1-iv21, 2017
17502017
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
The Lancet 393 (10185), 2051-2058, 2019
16002019
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Chang
Lancet Oncology 16, 630-7, 2015
15682015
Prophylactic cranial irradiation in extensive small-cell lung cancer
B Slotman, C Faivre-Finn, G Kramer, E Rankin, M Snee, M Hatton, ...
New England Journal of Medicine 357 (7), 664-672, 2007
13232007
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Novello, F Barlesi, R Califano, T Cufer, S Ekman, MG Levra, K Kerr, ...
Annals of Oncology 27, v1-v27, 2016
9902016
Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
Journal of Clinical Oncology 38 (25), 2830, 2020
8672020
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery …
T Treasure, L Lang-Lazdunski, D Waller, JM Bliss, C Tan, J Entwisle, ...
The lancet oncology 12 (8), 763-772, 2011
7742011
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis
DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013
7002013
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J Vansteenkiste, D De Ruysscher, WEE Eberhardt, E Lim, S Senan, ...
Annals of oncology 24, vi89-vi98, 2013
6412013
Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study
WFAR Verbakel, JP Cuijpers, D Hoffmans, M Bieker, BJ Slotman, ...
International Journal of Radiation Oncology* Biology* Physics 74 (1), 252-259, 2009
6202009
Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
DR Spigel, C Faivre-Finn, JE Gray, D Vicente, D Planchard, L Paz-Ares, ...
Journal of Clinical Oncology 40 (12), 1301, 2022
6192022
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer
FJ Lagerwaard, CJA Haasbeek, EF Smit, BJ Slotman, S Senan
International Journal of Radiation Oncology* Biology* Physics 70 (3), 685-692, 2008
6182008
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
BJ Slotman, H van Tinteren, JO Praag, JL Knegjens, SY El Sharouni, ...
The Lancet 385 (9962), 36-42, 2015
5902015
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
5382014
Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non–small-cell lung cancer: a population-based time-trend analysis
D Palma, O Visser, FJ Lagerwaard, J Belderbos, BJ Slotman, S Senan
Journal of clinical oncology 28 (35), 5153-5159, 2010
5342010
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
S Senthi, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan
The lancet oncology 13 (8), 802-809, 2012
5142012
European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer
D De Ruysscher, C Faivre-Finn, U Nestle, CW Hurkmans, C Le Péchoux, ...
Journal of clinical oncology 28 (36), 5301-5310, 2010
495*2010
PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced …
S Senan, A Brade, L Wang, J Vansteenkiste, S Dakhil, B Biesma, ...
Journal of clinical oncology 34 (9), 953-962, 2016
4822016
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non–small-cell lung cancer
AB Ashworth, S Senan, DA Palma, M Riquet, YC Ahn, U Ricardi, ...
Clinical lung cancer 15 (5), 346-355, 2014
4452014
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and …
C Le Péchoux, A Dunant, S Senan, A Wolfson, E Quoix, C Faivre-Finn, ...
The lancet oncology 10 (5), 467-474, 2009
4312009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20